ANDA 76169, held by Barr Laboratories. Fexofenadine Hydrochloride.
As of Nov 21, 2026, ANDA 76169 (Fexofenadine Hydrochloride), held by Barr Laboratories, was first approved by FDA on Jul 13, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 13, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fexofenadine Hydrochloride60MG · capsule;oral | Fexofenadine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters